Adam J Mrisho

Background

About Adam J Mrisho

Adam Mrisho with over 13 years’ experience in managerial and leadership in various programmatic specialities including HIV/AIDS care and treatment, Reproductive, Maternal, Newborn and Child Health (RMNCH)/Elimination of mother-to-child transmission (eMTCT) of HIV and syphilis, laboratory and supply chain management, and integrated TB/HIV initiatives in collaboration with the Government of Tanzania (GoT), other HIV implementing partners (IPs), community-based organisations (CBOs), and bilateral donors such as PEPFAR/CDC. Specifically relating to underserved populations, in January 2020 Dr. Mrisho led MDH’s successful rollout of Tabora’s community HTS program with focus in reaching KVP/AGYWs and other related targeted sub population i.e fisherfolk, mining communities and long track drivers in Community HIV Testing Services that improved from 3% to 18% contribution to HTS Total positive in Tabora region by 2020. Also, under his leadership, over a 9-month period in 2020, community interventions for KVP resulted in 2601 new clients knowing their status to reach UNAIDS 1st 95. This was achieved through Dr. Mrisho’s ability to develop trusting and collaborative working relationships with KVP peer groups, KVP Forum, Community Advocacy IPs, and the GoT under RCHMTs. Dr. Mrisho has also led the rollout of HIV SELF TEST programs to reach more KVPs as per New National HTS guideline through their networks and PREP to consented HIV Negative as a prevention package to risk sub population (KVPs) to reach epidemic control. Dr. Mrisho was also Clinical and Strategic Information Manager for MDH’s Kagera Regional programs. For the past five years, Dr Mrisho has worked with Regional and District Health Management Teams to ensure Kagera, Geita and Tabora regions achieve set national and donor targets, including early identification through targeted testing in reaching sub populations ( KVP, AGYWs) and retention, and that HIV/AIDS quality of care is delivered per national guidelines in MDH-supported facilities. Under his leadership in Geita region (with 6 district councils), he has worked with RHMTS and other partners to improve identification and linkage to ART-reducing treatment gap from 19% to 5% by September 2019, HVL coverage from 76% to 90% by September 2020, HEID below 2 months coverage from 33% to 80% by September 2020, and Isoniazid Preventive Therapy (IPT) coverage among PLHIV on ART from 49% in Sept 2019 to 82% in Dec 2020uptake and ever completed IPT among current PLHIV on ART from 69% in Sept 2018 to 91% in Sept 2019